Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 2 minute read Pharma Industry News Sol-Gel acquires Gorlin syndrome drug candidate Patidegib from PellePharm Sol-Gel Technologies, an Israel-based dermatology company, has acquired patidegib, a Gorlin syndrome drug candidate in phase 3 development,… byRaghuram KadariJanuary 31, 2023